Control of Assistive Devices Via Brain-Computer Interface Technology

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
Neuralink Corp
Study ID
NCT06710626
Status
Enrolling By Invitation

Conditions

  • Amyotrophic Lateral Sclerosis (ALS)
  • Quadriplegia
  • Spinal Cord Injury (SCI)
  • Spinal Cord Injury Cervical
  • Tetraplegia/Tetraparesis

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Assistive Robotic Arm — DEVICE
    The intervention involves using the N1 Implant, a wireless brain-computer interface (BCI), to enable participants to control the Assistive Robotic Arm through neural signals.

Study Details

The CONVOY Study is a clinical trial designed to explore the feasibility of participants from the PRIME Study (NCT06429735) using the N1 Implant to control various assistive devices. The main goal is to determine whether participants can successfully modulate their brain activity to control devices, such as an Assistive Robotic Arm (ARA). This study will assess the effectiveness, consistency, and safety of neural control using the ARA and other assistive devices.

Key Dates

Start date
Nov 25, 2024
Status verified
Jun 2025
Primary completion
May 25, 2031
Completion
May 25, 2031

Study Design

Enrollment
3 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Other: Single

Primary Outcome Measure

Ability of participants to modulate brain activity for controlling an assistive device via the N1 Implant. [ Time Frame: 3-months following first use of the assistive device ]

Locations (1)

FacilityCityStateZIPSite coordinators
Barrow Neurological InstitutePhoenixArizona85013-

Find similar trials in Phoenix, AZ

By research site
Barrow Neurological Institute· Phoenix, AZ

Related Studies